Acute Ischemic Stroke. Cerebral infarction
Conditions
Interventions
Intervention group: (Ticagrelor/Aspirin): Aspirin (a loading dose of 100-300 mg as one to three tablets of 100 mg on the first day and then 80 mg once a day) together with Ticagrelor (loading dose of
Sponsors
Ahvaz University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Diagnosing Ischemic Stroke or TIA based on history and neurological examination and Imaging findings by a Specialist
Exclusion criteria
Exclusion criteria: More than 24 hours have passed since the onset of symptoms Thrombolytic therapy or Thrombectomy Intracranial hemorrhage Vascular malformations The presence of contraindications to Aspirin, Clopidogrel or Ticagrelor Severe or moderate Ischemic Stroke (NIHSS>>12) Lack of patient consent to enter the study The presence of acute coronary syndrome at the beginning of hospitalization cardioembolic Stroke or TIA
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Recurrence of stroke. Timepoint: 21 days, 3 months, 6 months from the beginning of the study. Method of measurement: Clinical history and in case of recurrence of stroke symptoms, imaging findings. | — |
Secondary
| Measure | Time frame |
|---|---|
| Intracranial hemorrhage, Dyspnea, Mortality. Timepoint: 21 days, 3 months, 6 months from the beginning of the study. Method of measurement: Clinical history and Imaging findings in case of Symptoms related to Intracranial hemorrhage or Dyspnea. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMaryam Alwanian
Ahvaz University of Medical Sciences
Outcome results
None listed